Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Bergval IL, Schuitema AR, Klatser PR, Anthony RM.

J Antimicrob Chemother. 2009 Sep;64(3):515-23. doi: 10.1093/jac/dkp237. Epub 2009 Jul 4.

2.

Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.

Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML.

BMC Microbiol. 2009 Feb 19;9:39. doi: 10.1186/1471-2180-9-39.

3.

Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.

Guo H, Seet Q, Denkin S, Parsons L, Zhang Y.

J Med Microbiol. 2006 Nov;55(Pt 11):1527-31.

PMID:
17030912
4.

Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.

Valvatne H, Syre H, Kross M, Stavrum R, Ti T, Phyu S, Grewal HM.

J Antimicrob Chemother. 2009 Oct;64(4):694-701. doi: 10.1093/jac/dkp292. Epub 2009 Aug 26.

PMID:
19710078
5.

Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.

Evans J, Stead MC, Nicol MP, Segal H.

J Antimicrob Chemother. 2009 Jan;63(1):11-6. doi: 10.1093/jac/dkn433. Epub 2008 Oct 21.

PMID:
18940875
6.

Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.

Abdelaal A, El-Ghaffar HA, Zaghloul MH, El Mashad N, Badran E, Fathy A.

Ann Clin Microbiol Antimicrob. 2009 Jan 30;8:4. doi: 10.1186/1476-0711-8-4. Erratum in: Ann Clin Microbiol Antimicrob. 2009;8(5). doi: 10.1186/1476-0711-8-5.

7.

The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.

Tseng ST, Tai CH, Li CR, Lin CF, Shi ZY.

J Microbiol Immunol Infect. 2015 Jun;48(3):249-55. doi: 10.1016/j.jmii.2013.08.018. Epub 2013 Nov 1.

8.

Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.

Kozhamkulov U, Akhmetova A, Rakhimova S, Belova E, Alenova A, Bismilda V, Chingissova L, Ismailov S, Ramanculov E, Momynaliev K.

Jpn J Infect Dis. 2011;64(3):253-5.

9.

Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.

Coll P, Aragón LM, Alcaide F, Espasa M, Garrigó M, González J, Manterola JM, Orús P, Salvadó M.

Microb Drug Resist. 2005 Summer;11(2):107-14.

PMID:
15910223
10.

Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.

Jiao WW, Mokrousov I, Sun GZ, Li M, Liu JW, Narvskaya O, Shen AD.

Chin Med J (Engl). 2007 May 5;120(9):814-9.

PMID:
17531124
11.

Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.

Aragón LM, Navarro F, Heiser V, Garrigó M, Español M, Coll P.

J Antimicrob Chemother. 2006 May;57(5):825-31. Epub 2006 Mar 17.

PMID:
16547071
12.

Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.

Hristea A, Otelea D, Paraschiv S, Macri A, Baicus C, Moldovan O, Tinischi M, Arama V, Streinu-Cercel A.

Indian J Med Microbiol. 2010 Jul-Sep;28(3):211-6. doi: 10.4103/0255-0857.66474.

14.

Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.

Yao C, Zhu T, Li Y, Zhang L, Zhang B, Huang J, Fu W.

Clin Microbiol Infect. 2010 Nov;16(11):1639-43. doi: 10.1111/j.1469-0691.2010.03267.x.

15.

Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.

Caws M, Duy PM, Tho DQ, Lan NT, Hoa DV, Farrar J.

J Clin Microbiol. 2006 Jul;44(7):2333-7.

16.
17.

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D.

Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9.

18.

High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.

Choi GE, Lee SM, Yi J, Hwang SH, Kim HH, Lee EY, Cho EH, Kim JH, Kim HJ, Chang CL.

J Clin Microbiol. 2010 Nov;48(11):3893-8. doi: 10.1128/JCM.00396-10. Epub 2010 Sep 15.

20.

Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.

Bolotin S, Alexander DC, Chedore P, Drews SJ, Jamieson F.

J Antimicrob Chemother. 2009 Aug;64(2):263-6. doi: 10.1093/jac/dkp183. Epub 2009 Jun 11.

PMID:
19520719

Supplemental Content

Support Center